Frank G. Basile

Frank G. Basile, MD, currently serves as Executive Director at Schrödinger, beginning in February 2024. Prior to this role, Frank held various senior positions in clinical development, including Executive Director of Clinical Development-Oncology at Nimbus Therapeutics and Executive Director-Clinical Development at Nurix Therapeutics. Frank’s extensive experience includes significant contributions at Sanofi as Clinical Research Director for Multiple Myeloma and as Medical Director at Agios Pharmaceuticals, focusing on early oncology development. Frank has also practiced as a Hematologist-Oncologist across several healthcare institutions, including Cape Cod Healthcare and Lowell General Hospital. Academic training includes an MD from Tufts University School of Medicine and a B.S. from Stony Brook University.